Research Jul 29, 2026
Eli Lilly Just Paid $3.8 Billion for the Same Molecule People Get From a Toad
Eli Lilly's acquisition of AtaiBeckley centers on a synthetic version of 5-MeO-DMT — the compound underground "Bufo" ceremonies harvest from a wild toad. What the deal signals for the toad, the field, and the science.
Research Jul 29, 2026
Everyone Knows Which Pill They Got. The FDA Just Said What To Do About It.
Functional unblinding is the methodological problem at the centre of psychedelic research. After three years in draft, the FDA's final trial guidance says how sponsors must handle it.
Research Feb 14, 2026
The Clinical Revolution: Psilocybin and 5-MeO-DMT Move from Underground to Evidence-Based Medicine
Rigorous clinical trials are providing what decades of anecdotal evidence couldn't: peer-reviewed data showing these compounds may offer rapid, sustained relief.